How are Nanoparticle Drug Delivery Systems for Cancer Treatments?

At just 1–100 nanometres in size, Nanoparticles are the next big thing in cancer treatment.

Designed to enter tissues at a molecular level, they can help therapeutic agents pass through biologic barriers, mediate molecular interactions and identify molecular changes.

A bold new platform for cancer diagnostics and therapy, these particles can be used as carriers in a targeted drug delivery approach, minimizing drug-originated systemic toxic effects.

The development and application of engineered nanoparticles to more effectively treat cancer have witnessed significant advancement over the past several decades.

Nanotechnology is a rapidly evolving domain solving various issues associated with conventional drug therapeutics, including poor water solubility, lack of targeting capability, non-specific distribution, systemic toxicity, and low therapeutic index.

Download our report to know more about current research trends and promising new developments in the use of nanoparticles to fight cancer.